Theralase Technologies Inc. announced a non-brokered private placement to issue 6,666,670 Units at a price of CAD 0.18 per unit for the gross proceeds of CAD 1,200,000.6 on February 5, 2024. Each Unit consists of one common share and one common share purchase warrant. Each Warrant entitles the holder to acquire an additional Common Share at an exercise price of CAD 0.25 per share for a period of 5 years following the date of issuance.

In connection with the Offering, the Company paid a broker?s fee of CAD 1,500 in cash and issued 4,166 non-transferrable broker warrants of the Company. All securities issued under the Offering will be subject to a four month and one day hold period from the closing date under applicable Canadian securities laws, which expires on June 6, 2024. The Offering is subject to receipt of final acceptance from the TSX Venture Exchange.

The transaction included participation from certain insiders of the company for an aggregate of 1,310,502 units for gross proceeds of CAD 235,890. The TSX Venture Exchange has accepted for filing documentation with respect to anon-brokered private placement announced on February 5, 2024. The transaction included participation from 35 placees and 7 insiders with total existing insider involvement of 1,310,502 shares.